Additionally, the expression levels of FOXP3, FOXO3, FOXO1, FOXA2, and FOXM1 were found to be elevated in GBM tissues from the TCGA database compared to non-tumor brain tissues, while the level of FOXQ1 was reduced (Fig. 1C, Fig. S2A). This evidence concerns the gene FOXM1 and glioblastoma.